BidaskClub lowered shares of Biohaven Pharmaceutical Holding Co Ltd (NASDAQ:BHVN) from a strong-buy rating to a buy rating in a report issued on Wednesday.
BHVN has been the topic of several other reports. Morgan Stanley began coverage on Biohaven Pharmaceutical Holding Co in a research report on Wednesday, May 31st. They issued an overweight rating on the stock. Needham & Company LLC initiated coverage on Biohaven Pharmaceutical Holding Co in a report on Tuesday, May 30th. They set a buy rating and a $30.00 price objective on the stock. Piper Jaffray Companies reissued a buy rating and set a $54.00 price objective on shares of Biohaven Pharmaceutical Holding Co in a report on Tuesday, September 12th. Zacks Investment Research raised Biohaven Pharmaceutical Holding Co from a sell rating to a hold rating in a report on Friday, September 8th. Finally, William Blair initiated coverage on Biohaven Pharmaceutical Holding Co in a report on Tuesday, May 30th. They set an outperform rating and a $46.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. The stock has an average rating of Buy and a consensus price target of $43.25.
Biohaven Pharmaceutical Holding Co (NASDAQ BHVN) opened at 37.18 on Wednesday. The company’s 50-day moving average price is $31.72 and its 200 day moving average price is $26.70. The firm’s market capitalization is $1.34 billion. Biohaven Pharmaceutical Holding Co has a 52-week low of $17.00 and a 52-week high of $39.51.
COPYRIGHT VIOLATION WARNING: This news story was originally published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://www.chaffeybreeze.com/2017/09/21/biohaven-pharmaceutical-holding-co-ltd-bhvn-lowered-to-buy-at-bidaskclub.html.
About Biohaven Pharmaceutical Holding Co
Biohaven Pharmaceutical Holding Company Ltd. is a United States-based biopharmaceutical company. The Company is engaged in the identification and development of clinical-stage compounds targeting orphan neurologic indications and other neurological pathways. It has a portfolio of multiple late-stage drug candidates.
Receive News & Ratings for Biohaven Pharmaceutical Holding Co Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biohaven Pharmaceutical Holding Co Ltd and related companies with MarketBeat.com's FREE daily email newsletter.